Continuous Glucose Monitoring Use in Clinical Trials for On-Market Diabetes Drugs.


Journal

Clinical diabetes : a publication of the American Diabetes Association
ISSN: 0891-8929
Titre abrégé: Clin Diabetes
Pays: United States
ID NLM: 8406985

Informations de publication

Date de publication:
Apr 2021
Historique:
entrez: 14 5 2021
pubmed: 15 5 2021
medline: 15 5 2021
Statut: ppublish

Résumé

To the best of our knowledge, there are no published data on the historical and recent use of CGM in clinical trials of pharmacological agents used in the treatment of diabetes. We analyzed 2,032 clinical trials of 40 antihyperglycemic therapies currently on the market with a study start date between 1 January 2000 and 31 December 2019. According to ClinicalTrials.gov, 119 (5.9%) of these trials used CGM. CGM usage in clinical trials has increased over time, rising from <5% before 2005 to 12.5% in 2019. However, it is still low given its inclusion in the American Diabetes Association's latest guidelines and known limitations of A1C for assessing ongoing diabetes care.

Identifiants

pubmed: 33986569
doi: 10.2337/cd20-0049
pii: CD200049
pmc: PMC8061554
doi:

Banques de données

figshare
['10.2337/figshare.13423988']

Types de publication

Journal Article

Langues

eng

Pagination

160-166

Informations de copyright

© 2021 by the American Diabetes Association.

Références

Diabetes Technol Ther. 2015 Aug;17(8):548-54
pubmed: 25961446
Diabetes Technol Ther. 2015 Nov;17(11):787-94
pubmed: 26171659
Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S3-S13
pubmed: 26784127
Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S223-33
pubmed: 26784126
J Diabetes Sci Technol. 2009 Jul 01;3(4):981-5
pubmed: 20144349
Diabetes Technol Ther. 2000;2 Suppl 1:S13-8
pubmed: 11469627
J Diabetes Sci Technol. 2017 Jan;11(1):59-67
pubmed: 27566735
J Diabetes Complications. 2017 Jan;31(1):280-287
pubmed: 27818105
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
Diabetes Care. 2019 Mar;42(3):400-405
pubmed: 30352896
Diabetes Technol Ther. 2017 Jun;19(S3):S25-S37
pubmed: 28585879
Diabetes Care. 2017 Dec;40(12):1622-1630
pubmed: 29162582
Diabetes Technol Ther. 2000 Spring;2(1):49-56
pubmed: 11467320
Diabetes Technol Ther. 2017 Jul;19(7):391-399
pubmed: 28530490
J Diabetes Sci Technol. 2015 Mar 23;9(5):1021-6
pubmed: 25802469
Diabetes Care. 2018 Jun;41(6):e92-e94
pubmed: 29784704
Diabetes Technol Ther. 2015 Mar;17(3):177-86
pubmed: 25436913
Diabetes Care. 2018 Nov;41(11):2370-2376
pubmed: 30201847
J Diabetes Sci Technol. 2014 Jul;8(4):699-708
pubmed: 24876423
J Diabetes Sci Technol. 2015 Mar;9(2):209-14
pubmed: 25370149

Auteurs

Bradley Q Fox (BQ)

Close Concerns, San Francisco, CA.

Peninah F Benjamin (PF)

Close Concerns, San Francisco, CA.
Dartmouth College, Hanover, NH.

Ammara Aqeel (A)

Close Concerns, San Francisco, CA.
Duke University, Durham, NC.

Emily Fitts (E)

The diaTribe Foundation, San Francisco, CA.

Spencer Flynn (S)

Close Concerns, San Francisco, CA.

Brian Levine (B)

Close Concerns, San Francisco, CA.

Elizaveta Maslak (E)

Close Concerns, San Francisco, CA.
Dartmouth College, Hanover, NH.

Rebecca L Milner (RL)

Close Concerns, San Francisco, CA.

Benjamin Ose (B)

Close Concerns, San Francisco, CA.
Dartmouth College, Hanover, NH.

Michael Poeschla (M)

Close Concerns, San Francisco, CA.

Meghna Ray (M)

Close Concerns, San Francisco, CA.
Dartmouth College, Hanover, NH.

Maeve Serino (M)

Close Concerns, San Francisco, CA.

Sahaj S Shah (SS)

Close Concerns, San Francisco, CA.

Kelly L Close (KL)

Close Concerns, San Francisco, CA.
The diaTribe Foundation, San Francisco, CA.

Classifications MeSH